The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Research Funding - AB Science (Inst); Arcus Ventures (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Kura Oncology (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst); Samsung Bioepis (Inst); Tessa Therapeutics (Inst)
 
Honoraria - Ipsen; Pfizer; Roche
Research Funding - Kura Oncology; MSD; NALURI SDN BHD
A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR).
 
Gwo Fuang Ho
No Relationships to Disclose
 
Soo-Chin Lee
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - ASLAN Pharmaceuticals; Bayer; Eisai; Epizyme; Karyopharm Therapeutics; Pfizer; Taiho Pharmaceutical
Expert Testimony - Novartis
Travel, Accommodations, Expenses - ACT Genomics; Novartis; Pfizer; Roche
 
Joanna Lim
No Relationships to Disclose
 
Anita Zarina Bustam
Research Funding - MSD (Inst); Prestige BioPharma (Inst)
 
Siew Eng Lim
No Relationships to Disclose
 
Marniza Saad
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Cipla; Eisai; Ipsen; Johnson&Johnson; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; BMS; Johnson&Johnson; Merck; MSD; Novartis; Viatris
Research Funding - Johnson & Johnson; MSD
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
 
Natalie Ngoi
No Relationships to Disclose
 
Nur Fadhlina Abdul Satar
No Relationships to Disclose
 
Rozita Abdul Malik
Research Funding - AstraZeneca (Inst); Novartis (Inst); Zeria Pharmaceutical (Inst)
 
Adlinda Alip
No Relationships to Disclose
 
Kian Boon Law
No Relationships to Disclose
 
Yok Yong Toh
No Relationships to Disclose
 
Jia Wern Pan
Patents, Royalties, Other Intellectual Property - Patent pending for an oncology biomarker
 
Soo Hwang Teo
Speakers' Bureau - AstraZeneca; Pfizer; Roche